Showing all 3 results

  • Placeholder
    In Stock

    Apixaban Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.

    Active IngredientStrengthPrimary Clinical Function
    Apixaban USP/Ph.Eur.2.5 mgThe Dose-Reduction Unit: Used for patients with specific risk factors (Age ≥80, Weight ≤60kg, or high Creatinine) to minimize bleeding.
    Apixaban USP/Ph.Eur.5 mgThe Therapeutic Anchor: The standard maintenance dose for stroke prevention in Atrial Fibrillation and DVT treatment.
    ExcipientsProprietary MatrixRapid-Dissolution System: Engineered to ensure a consistent $T_{max}$ of approx. 3 to 4 hours for reliable protection.
  • Placeholder
    In Stock

    Atorvastatin & Aspirin and Clopidogrel Tablets

    Free

    Product Composition & Strength

    We supply this product typically in a Capsule-in-Capsule or Multi-Particulate Tablet format to ensure the chemical stability of the three distinct APIs.

    Active IngredientStrengthPrimary Clinical Function
    Atorvastatin (as Calcium) USP10 mg / 20 mgThe Lipid Stabilizer: Lowers cholesterol and prevents the growth of arterial blockages.
    Aspirin (Gastro-resistant) BP75 mg / 150 mgThe Primary Blood Thinner: Prevents initial platelet activation via the COX pathway.
    Clopidogrel (as Bisulphate) USP75 mgThe Secondary Blood Thinner: Provides high-level protection against stent thrombosis and recurrent stroke.
  • Placeholder
    In Stock

    Cefixime and Linezolid Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Potency Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive APIs.

    Active IngredientStrengthPrimary Clinical Function
    Cefixime (as Trihydrate) USP/Ph.Eur.200 mgThe Gram-Negative Anchor: Broad-spectrum bactericidal activity against H. influenzae, E. coli, and Salmonella.
    Linezolid USP/Ph.Eur.600 mgThe Gram-Positive Powerhouse: Bacteriostatic activity against multi-drug resistant Staphylococci and Streptococci.
    ExcipientsProprietary MatrixAdvanced Disintegration System: Engineered utilizing Super-Disintegrants to manage the large 800mg+ active payload, ensuring the tablet shatters rapidly for maximum absorption.